Delayed
Borsa Istanbul
03:29:07 2024-04-30 am EDT
|
5-day change
|
1st Jan Change
|
13.26
TRY
|
-0.82%
|
|
-1.70%
|
-5.81%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,312
|
2,298
|
2,928
|
2,207
|
10,498
|
10,710
|
Enterprise Value (EV)
1 |
2,543
|
2,644
|
3,270
|
2,629
|
10,706
|
11,284
|
P/E ratio
|
83.1
x
|
35.2
x
|
23.1
x
|
7.88
x
|
6.43
x
|
14.3
x
|
Yield
|
1.08%
|
0.26%
|
0.34%
|
0.68%
|
2.86%
|
-
|
Capitalization / Revenue
|
1.99
x
|
2.27
x
|
2.78
x
|
1.12
x
|
2.5
x
|
1.91
x
|
EV / Revenue
|
2.19
x
|
2.61
x
|
3.11
x
|
1.34
x
|
2.55
x
|
2.01
x
|
EV / EBITDA
|
15.5
x
|
25.4
x
|
20.2
x
|
7.48
x
|
16.8
x
|
12.5
x
|
EV / FCF
|
62.9
x
|
52
x
|
46.8
x
|
-69.2
x
|
106
x
|
32.5
x
|
FCF Yield
|
1.59%
|
1.92%
|
2.14%
|
-1.44%
|
0.94%
|
3.08%
|
Price to Book
|
1.58
x
|
1.6
x
|
1.67
x
|
1.08
x
|
2.67
x
|
0.95
x
|
Nbr of stocks (in thousands)
|
758,500
|
758,500
|
758,500
|
758,500
|
758,500
|
758,500
|
Reference price
2 |
3.049
|
3.030
|
3.860
|
2.910
|
13.84
|
14.12
|
Announcement Date
|
3/1/19
|
3/2/20
|
3/11/21
|
3/7/22
|
3/1/23
|
4/1/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,163
|
1,013
|
1,051
|
1,969
|
4,197
|
5,604
|
EBITDA
1 |
164.4
|
104.2
|
161.7
|
351.3
|
635.4
|
906
|
EBIT
1 |
119.9
|
61.3
|
110.5
|
283.9
|
559.2
|
554.9
|
Operating Margin
|
10.31%
|
6.05%
|
10.52%
|
14.42%
|
13.33%
|
9.9%
|
Earnings before Tax (EBT)
1 |
46.66
|
63.59
|
122.6
|
301.5
|
1,625
|
941.5
|
Net income
1 |
27.83
|
65.33
|
126.6
|
279.9
|
1,632
|
747.7
|
Net margin
|
2.39%
|
6.45%
|
12.04%
|
14.22%
|
38.88%
|
13.34%
|
EPS
2 |
0.0367
|
0.0861
|
0.1669
|
0.3691
|
2.151
|
0.9858
|
Free Cash Flow
1 |
40.41
|
50.86
|
69.84
|
-37.98
|
100.9
|
347.2
|
FCF margin
|
3.47%
|
5.02%
|
6.64%
|
-1.93%
|
2.4%
|
6.2%
|
FCF Conversion (EBITDA)
|
24.58%
|
48.81%
|
43.19%
|
-
|
15.88%
|
38.32%
|
FCF Conversion (Net income)
|
145.19%
|
77.86%
|
55.16%
|
-
|
6.18%
|
46.44%
|
Dividend per Share
2 |
0.0330
|
0.008000
|
0.0132
|
0.0198
|
0.3955
|
-
|
Announcement Date
|
3/1/19
|
3/2/20
|
3/11/21
|
3/7/22
|
3/1/23
|
4/1/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
231
|
346
|
342
|
422
|
208
|
574
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.405
x
|
3.321
x
|
2.115
x
|
1.202
x
|
0.3281
x
|
0.634
x
|
Free Cash Flow
1 |
40.4
|
50.9
|
69.8
|
-38
|
101
|
347
|
ROE (net income / shareholders' equity)
|
2.04%
|
4.32%
|
7.93%
|
14.7%
|
54.6%
|
6.94%
|
ROA (Net income/ Total Assets)
|
3.54%
|
1.7%
|
2.71%
|
5.41%
|
7.3%
|
2.48%
|
Assets
1 |
787.1
|
3,839
|
4,664
|
5,171
|
22,364
|
30,121
|
Book Value Per Share
2 |
1.930
|
1.890
|
2.320
|
2.700
|
5.180
|
14.80
|
Cash Flow per Share
2 |
0.2000
|
0.2400
|
0.3800
|
0.5400
|
0.6300
|
0.5500
|
Capex
1 |
70
|
95.2
|
45.7
|
115
|
316
|
340
|
Capex / Sales
|
6.02%
|
9.4%
|
4.34%
|
5.83%
|
7.53%
|
6.06%
|
Announcement Date
|
3/1/19
|
3/2/20
|
3/11/21
|
3/7/22
|
3/1/23
|
4/1/24
|
|
1st Jan change
|
Capi.
|
---|
| -5.81% | 313M | | +4.70% | 75.24B | | +1.09% | 46.91B | | -3.94% | 30.9B | | +12.68% | 18.41B | | -9.69% | 11.65B | | +8.37% | 11.45B | | -7.09% | 9.85B | | +5.92% | 9.45B | | +7.00% | 9.37B |
Diversified Chemicals
|